After a down 2016 in which Laval, Canada-based Valeant Pharmaceuticals slumped 85.3 percent, Zacks Equity Research predicted the stock's future in 2017.
The Latest
Clifton, N.J.-based EndoLogic acquired the rights to Renzapride from Cambridge, United Kingdom, based- Alizyme.
Namur, Belgium-based VolitionRx's Nu.Q colorectal cancer screening triage test gained a CE mark.
A pilot case unlike any other — Massachusetts General Hospital transplants hepatitis-C tainted liver
Born with biliary atresia, Ben Blake, 26, underwent his first liver transplant when he was seven-months old. Twenty years later, his liver was failing and he needed a replacement.
Kellyanne Conway, a senior advisor to President-elect Donald Trump, told MSNBC no one with health insurance will lose their coverage if the Republican administration repeals and replaces the ACA.
Illinois Gastroenterology Group, based in the Chicago area, and SonarMD developed Project Sonar, an intensive medical home model to care for patients with Crohn's disease. The model, applied across the 20-physician specialty group since 2014, has since gathered data to…
Hopkins, Minn.-based UnitedHealthcare is now including the FitBit Charge 2 device in the UnitedHealthcare Motion's wellness program, according to Investopedia.
JAMA published a study showing bundled payments yielded significant savings for patients undergoing joint replacement surgeries. Despite the savings, President-elect Donald Trump's pick to lead HHS, Rep. Tom Price, MD, has opposed the mandatory payment program, according to Kaiser Health…
Both the American Medical Association and American College of Physicians leaders sent letters to Congress seeking a delay for an ACA repeal until legislators fully vet a new health plan, according to MedPage Today.
Wells Fargo & Co. boosted Nashville, Tenn.-base AmSurg's rating from a "market perform" to an "outperform," according to Daily Quint.